Qt Imaging Holdings, INC

QT Imaging Holdings, Inc. announced the results of its 2026 Annual Stockholder Meeting, with key votes approving director elections, auditor ratification, and an equity incentive plan amendment.

QT Imaging Holdings, Inc. successfully closed a $10 million underwritten public offering of common stock and pre-funded warrants, securing capital for working capital and general corporate purposes.

QT Imaging Holdings announced first quarter 2026 financial results, reporting $6.5 million in revenue, a 133% year-over-year increase, alongside key strategic advancements including a new CPT code and loan maturity extension.

QT Imaging Holdings, Inc. announced significant compensation increases and equity grants for its CEO, Dr. Raluca Dinu, and CFO, Jay Jennings, effective March 20, 2026.

QT Imaging Holdings, Inc. reported record 2025 revenue of $18.9 million, surpassing guidance, and affirmed 2026 revenue guidance of $39 million, driven by scanner shipments and its new QTI Cloud Platform.

QT Imaging Holdings, Inc. has posted an investor presentation detailing robust Q4 2025 financial results, a positive 2026 revenue forecast, and key strategic advancements including CPT code approval and international expansion.

QT Imaging Holdings, Inc. reported a significant increase in revenue for the first quarter of 2026, driven by higher scanner sales, alongside continued investment in R&D and SG&A.

QT Imaging Holdings, Inc. reported a significant 339% increase in Q3 2025 revenue, driven by increased scanner sales and new distribution agreements, while also securing $18.18 million in a private placement post-quarter.

QT Imaging Holdings, Inc. announced a 110% revenue increase for the first half of 2025, driven by breast scanner sales, but reported a significantly wider net loss due to non-cash expenses.

QT Imaging Holdings saw revenue growth in Q1 2025 but reported a substantial net loss due to increased expenses and debt-related costs.

QT Imaging Holdings saw a significant increase in revenue during the third quarter of 2024, alongside strategic financial moves including debt restructuring and a private investment.

QT Imaging Holdings saw a significant increase in revenue during the second quarter of 2024, primarily driven by product sales, but the company continues to experience net losses.

QT Imaging Holdings, Inc. announced a significant revenue increase, uplisted to Nasdaq, and secured major distribution agreements in the Middle East, despite widening net losses for fiscal year 2025.

QT Imaging Holdings reports a \$9 million loss for 2024 and faces Nasdaq delisting, transitioning to the OTCQB Venture Market.

QT Imaging Holdings, Inc. has formalized its commitment to ethical business practices by adopting a comprehensive Code of Business Conduct and Ethics.

QT Imaging Holdings, Inc. Director Ross Taylor acquired 3,500 Restricted Stock Units, increasing his direct beneficial ownership to 60,578 shares.

QT Imaging Holdings Director Zeev Weiner increased his beneficial ownership of common stock and exercised stock options.

QT Imaging Holdings, Inc. Director James S. Greene was granted 3,500 Restricted Stock Units, vesting over approximately one year.

QT Imaging Holdings, Inc. Chief Financial Officer Jay Walter Jennings was granted 2,800 restricted stock units, vesting over three years.

QT Imaging Holdings, Inc. granted 3,500 Restricted Stock Units to Director and 10% Owner John C. Klock Jr., vesting over approximately one year.

QT Imaging Holdings, Inc. CEO Raluca Dinu acquired 519,500 restricted stock units, significantly increasing her beneficial ownership to 908,845 shares.

QT Imaging Holdings, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for July 28, 2026, to elect directors, ratify auditors, and approve an amendment to its equity incentive plan.

QT Imaging Holdings, Inc. announced strong second-quarter 2025 financial results with significant revenue growth, a strengthened balance sheet, and strategic initiatives including a Nasdaq uplisting effort and the launch of its QTI Cloud Platform.

QT Imaging Holdings, Inc. is convening its annual stockholder meeting to vote on key proposals including the election of directors, ratification of auditors, and a proposed reverse stock split aimed at maintaining Nasdaq listing compliance, following a year of significant revenue growth but also increased net losses and cash burn.

QT Imaging Holdings, Inc. filed an S-1/A registration statement detailing recent private placements, debt restructuring, and its strategy for commercializing breast imaging technology.

QT Imaging Holdings files an S-1 registration statement for the resale of up to 29.3 million common shares and warrants, following recent private placements and a reverse stock split.

QT Imaging Holdings files an amendment to its registration statement, covering the potential resale of 8.8 million shares of common stock by selling securityholders.

QT Imaging Holdings has filed a registration statement for the resale of up to 8.8 million shares of its common stock by selling securityholders, following a recent private placement.

QT Imaging Holdings, Inc. has filed a registration statement for the issuance of up to 43,795,000 shares of common stock and the resale of up to 17,711,129 shares and 889,364 warrants by selling securityholders following its merger with GigCapital5, Inc.

QT Imaging Holdings aims to raise capital and provide liquidity for selling securityholders through the registration of up to 43,795,000 shares of common stock and 889,364 warrants.

Dr. Raluca Dinu, CEO of QT Imaging Holdings, Inc., has filed an amended Schedule 13D, revealing a beneficial ownership of 7.0% of the company's common stock for investment purposes.

Dr. Avi S. Katz, a board member of QT Imaging Holdings, Inc., has updated his beneficial ownership stake to 6.2% of the company's common stock, primarily for investment purposes.

Dr. Raluca Dinu, CEO of QT Imaging Holdings, Inc., has filed a Schedule 13D disclosing beneficial ownership of 1,543,676 shares, representing 5.4% of the company's common stock.

Dr. Avi S. Katz and GigAcquisitions5, LLC have reported ceasing to be beneficial owners of more than five percent of QT Imaging Holdings, Inc.'s Common Stock as of March 21, 2025.

Alta Partners LLC has filed a Schedule 13G reporting beneficial ownership of 540,842 shares of QT Imaging Holdings, Inc. common stock.

Alta Partners LLC has reported a passive 5.6% ownership stake in QT Imaging Holdings, Inc., primarily through shares issuable upon warrant exercise.

Lynrock Lake LP, Lynrock Lake Partners LLC, and Cynthia Paul have collectively reported a 9.6% beneficial ownership stake in QT Imaging Holdings, Inc., as detailed in an amended Schedule 13G filing.

Emil D. Kakkis, CEO of Ultragenyx, and Jenny Soriano, MD at Kaiser Permanente, have jointly disclosed a passive 5.1% beneficial ownership stake in QT Imaging Holdings, Inc.